pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·May 9·1 min read
save

Biotech’s new company model; The super poop behind a startup launch; and more

Welcome back to another edition of Endpoints Weekly! Earnings season is in full swing, but we had plenty of original reporting and exclusives you won’t find anywhere else this week. Chief among them: Andrew Dunn’s ...

May 9, 2026·read at Endpoints ↗

May 9, 2026 06:00 AM EDT Weekly Biotech’s new com­pa­ny mod­el; The su­per poop be­hind a start­up launch; and more Nicole DeFeudis Senior Reporter Max Gelman Senior Editor Wel­come back to an­oth­er edi­tion of End­points Week­ly! Earn­ings sea­son is in full swing, but we had plen­ty of orig­i­nal re­port­ing and ex­clu­sives you won’t … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

source

Reporting by Endpoints.

read at Endpoints ↗
88 words · retrieved May 9
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Vyome Holdings, Inc

related stories

  • Aug 18Trump is taking credit for lower list prices. But a Biden-era law did a lot of the heavy liftingEndpoints
  • Aug 13'Incorrect and misleading' data prompted decision to pull Tavneos in EuropeEndpoints
  • Jul 23What’s behind the proposed pullback on remote patient monitoringEndpoints
  • Jul 20House lawmakers back trade probe of China biotech, sequencingEndpoints
  • Jul 14Former Akero team announces new I&I company, Avere, with China drugEndpoints